| Cepheid, Propelled By Seattle Chemists, Sells to Danaher for $4B | David Holley | 09/06/16 | San Francisco |
| Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More | Ben Fidler | 06/24/16 | National |
| Texas Roundup: Innovative Cities, Launches, & Deals, Deals, Deals! | David Holley | 06/21/16 | Texas |
| Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates | David Holley | 06/21/16 | Texas |
| Tour of Texas: Savara, Brainspace, JLabs, InCube, Trinity University | Angela Shah | 03/07/16 | Texas |
| Austin Biotech Savara Nets $20M in Series C for Phase 3 Study | David Holley | 03/01/16 | Texas |
| Savara Pharmaceuticals Garners $20,000,000 Series C Round | VentureDeal | 03/01/16 | Texas |
| Austin Biotech Savara Nets $10M to Develop Cystic Fibrosis Drug | Angela Shah | 10/06/14 | Texas |
| Savara Pharmaceuticals Lands $10,000,000 New Round | VentureDeal | 10/06/14 | Texas |
| Roundup: New Funds at Wisegate, Savara, Besomebody, & Dallas startups | Angela Shah | 06/17/14 | Texas |
| Savara Pharmaceuticals Obtains $4,493,581 New Funding Round | VentureDeal | 06/11/14 | Texas |
| Austin Startup Savara Wins Research Award for CF Therapy | Angela Shah | 10/17/13 | Texas |
| Savara Enters the Proving Ground With Inhalable Antibiotic for CF | Luke Timmerman | 05/01/13 | Texas |
| San Diego Life Sciences Roundup: Health IT, Illumina, & More | Bruce V. Bigelow | 03/22/13 | San Diego |
| UCSD Business School’s Venture Fund Joins Texas Startup’s $16M Deal | Bruce V. Bigelow | 03/20/13 | San Diego |
| Savara Pharmaceuticals Secures $16,000,000 Series B Funding Round | VentureDeal | 03/20/13 | Texas |
| Savara Pharmaceuticals Obtains $8,600,000 Series B Funding | VentureDeal | 06/12/12 | Texas |
